According to a survey conducted among U.S. rheumatologists in 2021, around 39 percent were aware that there are biosimilars to Rituxan (infliximab) that are also FDA approved but not launched yet, while around 83 percent of physicians stated that they were familiar with the FDA definition of a biosimilar product. This statistic illustrates the percentage of rheumatologists familiar with autoimmune biosimilars in the United States as of 2021.
Percentage of physicians familiar with autoimmune biosimilars in the United States as of 2021
Characteristic
Percentage of physicians
Familiar with the FDA definition of a biosimilar product
83%
Aware that a biosimilar to treat inflammation was FDA approved
96%
...of which realized that biosimilars to Humira (adalimumab) were also FDA approved but not launched
56%
...of which realized that biosimilars to Enbrel (etanercept) were also FDA approved but not launched
62%
...of which realized that biosimilars to Rituxan (infliximab) were also FDA approved but not launched
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Amgen. (September 22, 2021). Percentage of physicians familiar with autoimmune biosimilars in the United States as of 2021 [Graph]. In Statista. Retrieved December 21, 2024, from https://www.statista.com/statistics/1275610/share-of-physicians-familiar-with-autoimmune-biosimilars/
Amgen. "Percentage of physicians familiar with autoimmune biosimilars in the United States as of 2021." Chart. September 22, 2021. Statista. Accessed December 21, 2024. https://www.statista.com/statistics/1275610/share-of-physicians-familiar-with-autoimmune-biosimilars/
Amgen. (2021). Percentage of physicians familiar with autoimmune biosimilars in the United States as of 2021. Statista. Statista Inc.. Accessed: December 21, 2024. https://www.statista.com/statistics/1275610/share-of-physicians-familiar-with-autoimmune-biosimilars/
Amgen. "Percentage of Physicians Familiar with Autoimmune Biosimilars in The United States as of 2021." Statista, Statista Inc., 22 Sep 2021, https://www.statista.com/statistics/1275610/share-of-physicians-familiar-with-autoimmune-biosimilars/
Amgen, Percentage of physicians familiar with autoimmune biosimilars in the United States as of 2021 Statista, https://www.statista.com/statistics/1275610/share-of-physicians-familiar-with-autoimmune-biosimilars/ (last visited December 21, 2024)
Percentage of physicians familiar with autoimmune biosimilars in the United States as of 2021 [Graph], Amgen, September 22, 2021. [Online]. Available: https://www.statista.com/statistics/1275610/share-of-physicians-familiar-with-autoimmune-biosimilars/
